Where did you study?
I recently graduated from the research master program Cognitive and Clinical Neuroscience at Maastricht University. For my thesis project, I spent 8 months in Toronto where I investigated potential brain markers that could predict clinical outcome of rTMS in depressed people.

What is your role at Brainclinics?
My research at Brainclinics goes in a similar direction. We are currently aiming to build a guideline for treatment recommendation that can aid clinicians in choosing the most promising treatment for depression and AD(H)D based on the patient’s individual neurophysiological characteristics.
I am also involved in collecting EEG data and optimizing data analysis.

Why do you do what you do?
I’ve always been fascinated by the brain’s immense intricacy and by what it can accomplish. Unfortunately, this high complexity brings with it an increased risk for faults which can result in tremendous suffering and reductions in quality of life.
With today’s advances and scientific progress, we can already greatly reduce this burden for many people suffering from mental disorders. Nevertheless, there is still a lot to learn and many people cannot yet be helped with the currently available treatments. With this research, I hope to take part in improving treatment for mental disorders further in order to help more people in a better way.”